TY - JOUR
T1 - Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome?
AU - Godoy, Daniel Agustin
AU - Rabinstein, Alejandro
N1 - Publisher Copyright:
© 2015, Associacao Arquivos de Neuro-Psiquiatria. All rights reserved.
PY - 2015/10
Y1 - 2015/10
N2 - Objective: In certain situations, severe forms of Guillain-Barré syndrome (GBS) show no response or continue to deteriorate after intravenous immunoglobulin (IVIg) infusion. It is unclear what the best treatment option would be in these circumstances. Method: This is a case report on patients with severe axonal GBS in whom a second cycle of IVIg was used. Results: Three patients on mechanical ventilation who presented axonal variants of GBS, with autonomic dysfunction, bulbar impairment and Erasmus score > 6, showed no improvement after IVIg infusion of 400 mg/kg/d for 5 days. After 6 weeks, we started a second cycle of IVIg using the same doses and regimen as in the previous one. On average, 5 days after the second infusion, all the patients were weaned off mechanical ventilation and showed resolution of their blood pressure and heart rate fluctuations. Conclusions: A second cycle of IVIg may be an option for treating severe forms of GBS.
AB - Objective: In certain situations, severe forms of Guillain-Barré syndrome (GBS) show no response or continue to deteriorate after intravenous immunoglobulin (IVIg) infusion. It is unclear what the best treatment option would be in these circumstances. Method: This is a case report on patients with severe axonal GBS in whom a second cycle of IVIg was used. Results: Three patients on mechanical ventilation who presented axonal variants of GBS, with autonomic dysfunction, bulbar impairment and Erasmus score > 6, showed no improvement after IVIg infusion of 400 mg/kg/d for 5 days. After 6 weeks, we started a second cycle of IVIg using the same doses and regimen as in the previous one. On average, 5 days after the second infusion, all the patients were weaned off mechanical ventilation and showed resolution of their blood pressure and heart rate fluctuations. Conclusions: A second cycle of IVIg may be an option for treating severe forms of GBS.
KW - Acute inflammatory demyelinating polyradiculoneuropathy
KW - Flaccid acute paralysis
KW - Guillain-Barré syndrome
KW - Immunoglobulin
KW - Immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=84943787927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84943787927&partnerID=8YFLogxK
U2 - 10.1590/0004-282X20150136
DO - 10.1590/0004-282X20150136
M3 - Article
C2 - 26465402
AN - SCOPUS:84943787927
SN - 0004-282X
VL - 73
SP - 848
EP - 851
JO - Arquivos de neuro-psiquiatria
JF - Arquivos de neuro-psiquiatria
IS - 10
ER -